vs
Hagerty, Inc.（HGTY）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Hagerty, Inc.的季度营收约是Ultragenyx Pharmaceutical Inc.的1.9倍（$388.1M vs $207.3M），Hagerty, Inc.净利率更高（7.4% vs -62.0%，领先69.4%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 16.5%），Hagerty, Inc.自由现金流更多（$194.5M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 19.5%）
哈格蒂（Hagerty, Inc.）是美国知名汽车生活方式及会员服务企业，同时是全球规模最大的经典老爷车特种保险供应商，总部位于密歇根州特拉弗斯城，业务范围覆盖加拿大、德国及英国市场。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
HGTY vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $388.1M | $207.3M |
| 净利润 | $28.6M | $-128.6M |
| 毛利率 | — | — |
| 营业利润率 | 10.2% | -54.7% |
| 净利率 | 7.4% | -62.0% |
| 营收同比 | 16.5% | 25.9% |
| 净利润同比 | 238.4% | 3.5% |
| 每股收益（稀释后） | — | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $388.1M | $207.3M | ||
| Q3 25 | $380.0M | $159.9M | ||
| Q2 25 | $368.7M | $166.5M | ||
| Q1 25 | $319.6M | $139.3M | ||
| Q4 24 | $333.2M | $164.6M | ||
| Q3 24 | $323.4M | $139.5M | ||
| Q2 24 | $313.2M | $147.0M | ||
| Q1 24 | $271.7M | $108.8M |
| Q4 25 | $28.6M | $-128.6M | ||
| Q3 25 | $46.2M | $-180.4M | ||
| Q2 25 | $47.2M | $-115.0M | ||
| Q1 25 | $27.3M | $-151.1M | ||
| Q4 24 | $8.4M | $-133.2M | ||
| Q3 24 | $19.0M | $-133.5M | ||
| Q2 24 | $42.7M | $-131.6M | ||
| Q1 24 | $8.2M | $-170.7M |
| Q4 25 | 10.2% | -54.7% | ||
| Q3 25 | 9.0% | -106.9% | ||
| Q2 25 | 12.9% | -64.8% | ||
| Q1 25 | 8.1% | -102.6% | ||
| Q4 24 | 1.8% | -74.3% | ||
| Q3 24 | 3.1% | -94.6% | ||
| Q2 24 | 12.2% | -79.1% | ||
| Q1 24 | 4.5% | -151.9% |
| Q4 25 | 7.4% | -62.0% | ||
| Q3 25 | 12.2% | -112.8% | ||
| Q2 25 | 12.8% | -69.0% | ||
| Q1 25 | 8.5% | -108.5% | ||
| Q4 24 | 2.5% | -80.9% | ||
| Q3 24 | 5.9% | -95.7% | ||
| Q2 24 | 13.6% | -89.5% | ||
| Q1 24 | 3.0% | -156.8% |
| Q4 25 | — | $-1.28 | ||
| Q3 25 | — | $-1.81 | ||
| Q2 25 | — | $-1.17 | ||
| Q1 25 | — | $-1.57 | ||
| Q4 24 | — | $-1.34 | ||
| Q3 24 | — | $-1.40 | ||
| Q2 24 | — | $-1.52 | ||
| Q1 24 | — | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $160.2M | $421.0M |
| 总债务越低越好 | $177.9M | — |
| 股东权益账面价值 | $221.3M | $-80.0M |
| 总资产 | $2.1B | $1.5B |
| 负债/权益比越低杠杆越低 | 0.80× | — |
8季度趋势，按日历期对齐
| Q4 25 | $160.2M | $421.0M | ||
| Q3 25 | $290.5M | $202.5M | ||
| Q2 25 | $259.6M | $176.3M | ||
| Q1 25 | $232.7M | $127.1M | ||
| Q4 24 | $178.7M | $174.0M | ||
| Q3 24 | $208.9M | $150.6M | ||
| Q2 24 | $186.4M | $480.7M | ||
| Q1 24 | $131.2M | $112.3M |
| Q4 25 | $177.9M | — | ||
| Q3 25 | $104.4M | — | ||
| Q2 25 | $153.4M | — | ||
| Q1 25 | $132.6M | — | ||
| Q4 24 | $105.8M | — | ||
| Q3 24 | $122.9M | — | ||
| Q2 24 | $98.0M | — | ||
| Q1 24 | $91.5M | — |
| Q4 25 | $221.3M | $-80.0M | ||
| Q3 25 | $211.7M | $9.2M | ||
| Q2 25 | $172.3M | $151.3M | ||
| Q1 25 | $162.9M | $144.2M | ||
| Q4 24 | $150.3M | $255.0M | ||
| Q3 24 | $148.3M | $346.8M | ||
| Q2 24 | $94.4M | $432.4M | ||
| Q1 24 | $93.5M | $140.3M |
| Q4 25 | $2.1B | $1.5B | ||
| Q3 25 | $2.2B | $1.2B | ||
| Q2 25 | $2.0B | $1.3B | ||
| Q1 25 | $1.8B | $1.3B | ||
| Q4 24 | $1.7B | $1.5B | ||
| Q3 24 | $1.8B | $1.5B | ||
| Q2 24 | $1.7B | $1.6B | ||
| Q1 24 | $1.6B | $1.3B |
| Q4 25 | 0.80× | — | ||
| Q3 25 | 0.49× | — | ||
| Q2 25 | 0.89× | — | ||
| Q1 25 | 0.81× | — | ||
| Q4 24 | 0.70× | — | ||
| Q3 24 | 0.83× | — | ||
| Q2 24 | 1.04× | — | ||
| Q1 24 | 0.98× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $219.0M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $194.5M | $-100.8M |
| 自由现金流率自由现金流/营收 | 50.1% | -48.6% |
| 资本支出强度资本支出/营收 | 6.3% | 0.5% |
| 现金转化率经营现金流/净利润 | 7.67× | — |
| 过去12个月自由现金流最近4个季度 | $365.8M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $219.0M | $-99.8M | ||
| Q3 25 | $92.2M | $-91.4M | ||
| Q2 25 | $53.9M | $-108.3M | ||
| Q1 25 | $43.8M | $-166.5M | ||
| Q4 24 | $177.0M | $-79.3M | ||
| Q3 24 | $67.4M | $-67.0M | ||
| Q2 24 | $64.0M | $-77.0M | ||
| Q1 24 | $58.2M | $-190.7M |
| Q4 25 | $194.5M | $-100.8M | ||
| Q3 25 | $85.2M | $-92.7M | ||
| Q2 25 | $47.7M | $-110.7M | ||
| Q1 25 | $38.4M | $-167.8M | ||
| Q4 24 | $155.7M | $-79.5M | ||
| Q3 24 | $62.0M | $-68.6M | ||
| Q2 24 | $56.6M | $-79.0M | ||
| Q1 24 | $53.7M | $-193.9M |
| Q4 25 | 50.1% | -48.6% | ||
| Q3 25 | 22.4% | -58.0% | ||
| Q2 25 | 12.9% | -66.5% | ||
| Q1 25 | 12.0% | -120.5% | ||
| Q4 24 | 46.7% | -48.3% | ||
| Q3 24 | 19.2% | -49.2% | ||
| Q2 24 | 18.1% | -53.7% | ||
| Q1 24 | 19.8% | -178.2% |
| Q4 25 | 6.3% | 0.5% | ||
| Q3 25 | 1.8% | 0.8% | ||
| Q2 25 | 1.7% | 1.5% | ||
| Q1 25 | 1.7% | 1.0% | ||
| Q4 24 | 6.4% | 0.1% | ||
| Q3 24 | 1.7% | 1.2% | ||
| Q2 24 | 2.4% | 1.4% | ||
| Q1 24 | 1.7% | 3.0% |
| Q4 25 | 7.67× | — | ||
| Q3 25 | 2.00× | — | ||
| Q2 25 | 1.14× | — | ||
| Q1 25 | 1.61× | — | ||
| Q4 24 | 20.97× | — | ||
| Q3 24 | 3.55× | — | ||
| Q2 24 | 1.50× | — | ||
| Q1 24 | 7.10× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HGTY
暂无分部数据
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
